Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**
These parameters were used to quantify the respective levels in the plasma in accordance with the manufacturers instructions
Dont miss out-enhance your lighting capabilities with the GLP JDC1, where quality meets performance
Cost-Effectiveness Analysis If tirzepatide produces 50% more weight loss than semaglutide (which clinical trials suggest), the cost per pound lost might actually be similar despite higher absolute cost: Semaglutide at $199: $96 per pound lost (based on trial averages) Tirzepatide at $349: potentially $105 per pound lost if weight loss is proportionally higher The medications are relatively comparable in cost-effectiveness, making the choice based more on individual response than pure cost considerations
While the rate of weight loss may vary, both tirzepatide and semaglutide can help individuals lose a significant amount of weight and keep it off, especially when combined with a healthy diet and exercise
US$ 24.11
US$ 22.15
US$ 25.93
